Marker Therapeutics Competitors and Similar CompaniesClear all
Marker Therapeutics's competitors and similar companies include Celldex Therapeutics.
 Marker Therapeutics Marker Therapeutics is a biopharmaceutical company engaged in the discovery and development of immunotherapeutics for the treatment of cancer, infectious diseases, autoimmune disorders, and transplant tissue rejection. |  Celldex Therapeutics Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development. | |
Founding Date | Founding Date 2018 | Founding Date 1983 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Houston, US HQ | Locations Hampton, US HQ Fall River, US Needham, US New Haven, US |
Employees | Employees 888% decrease | Employees 1608% increase |
Valuation ($) | Valuation ($) 36.5 m | Valuation ($) 1.9 b |
Financial | ||
Revenue (est.) | Revenue (est.) $3.5m (FY, 2025) | Revenue (est.) $1.5m (FY, 2025) |
Net income | Net income ($12.2m) (FY, 2025) | Net income ($258.8m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Celldex Therapeutics
HQ
Hampton, US
Employees
160↑ 8% increase
Celldex Therapeutics (formerly Avant Immunotherapeutics) is a biopharmaceutical company that specializes in monoclonal and bispecific antibodies development.
View company